HUTCHMED (China) (HMDCF) Other Operating Expenses (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Other Operating Expenses came in at $16.4 million in Q2 2021, up 136.15% year-over-year from $6.9 million in Q2 2020, and up 123.21% quarter-over-quarter from -$70.7 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Other Operating Expenses (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Other Operating Expenses for 4 consecutive years, with $16.4 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Other Operating Expenses rose 136.15% year-over-year to $16.4 million in Q2 2021; TTM through Jun 2021 was -$143.5 million, a 18.93% increase from a year earlier, with the FY2025 full-year figure at -$21000.0, down 310.0% from the prior year.
- Other Operating Expenses was $16.4 million for Q2 2021 at HUTCHMED (China), up from -$70.7 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $122.9 million in Q2 2018 and troughed at -$130.8 million in Q2 2019.
- A 4-year average of -$13.0 million and a median of -$42.0 million in 2018 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 207.37% in 2019, down 213.01% in 2019.
- Over 4 years, Other Operating Expenses stood at $42.9 million in 2018, then plunged by 205.82% to -$45.4 million in 2019, then climbed by 0.09% to -$45.4 million in 2020, then soared by 136.15% to $16.4 million in 2021.
- The last three Other Operating Expenses figures came in at $16.4 million (Q2 2021), -$70.7 million (Q1 2021), and -$45.4 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 16.40 Mn |
| Mar 31, 2021 | -70.67 Mn |
| Jun 30, 2020 | -45.36 Mn |
| Mar 31, 2020 | -43.88 Mn |
| Dec 31, 2019 | -45.40 Mn |
| Sep 30, 2019 | -42.38 Mn |
| Jun 30, 2019 | -130.83 Mn |
| Mar 31, 2019 | 44.74 Mn |
| Dec 31, 2018 | 42.91 Mn |
| Sep 30, 2018 | 37.50 Mn |
| Jun 30, 2018 | 122.94 Mn |
| Mar 31, 2018 | -41.67 Mn |